B.S., Yale University, 2002; M.P.H., The Ohio State University, 2003; Ph.D., University of Pittsburgh, 2008
Area(s) of Specialization:
Cancer epidemiology, women's health, breast cancer, endocrine disruption
My research seeks to identify modifiable risk factors for breast cancer, with the ultimate goal of reducing breast cancer morbidity and mortality. Specifically, my research focuses on modifiable factors that may mediate breast cancer risk through hormonal pathways, including depression and/or antidepressant use, endocrine-disrupting chemicals such as bisphenol-A (BPA) or phthalates, and obesity and metabolic disease. I seek to understand how these factors may impact breast cancer risk and mammographic density (a strong breast cancer risk factor).
Reeves KW, Schneider S, Xue J, Kannan K, Mason H, Johnson M, Makari-Judson G, Díaz-Santana M. Bisphenol-A in breast adipose tissue of breast cancer cases and controls. Environmental Research. 2018; 167: 735-738. PMC in process.
Kiridly-Calderbank JF, Sturgeon SR, Kroenke CH, Reeves KW. Antidepressant use and risk of colorectal cancer in the Women’s Health Initiative. Cancer Epidemiology Biomarkers and Prevention. 2018; 27:892-898. PMID: 29789327
Reeves KW, Pennell M, Foraker RE, Crandall CJ, Stefanick M, Paskett ED. Predictors of vasomotor symptoms among breast cancer survivors. Journal of Cancer Survivorship. 2018; 12(3): 379-387. PMCID: PMC5955842
Reeves KW, Okereke OI, Qian J, Tamimi RM, Eliassen AH, Hankinson SE. Depression, antidepressant use and breast cancer risk in pre- and postmenopausal women: A prospective cohort study. Cancer Epidemiology Biomarkers and Prevention. 2017; 27(3):306-314. PMCID: PMC5835185
Reeves KW, Okereke OI, Qian J, Tworoger SS, Rice MS, Hankinson SE. Antidepressant use and circulating prolactin levels. Cancer Causes and Control. 2016. 27:853-861. PMCID: PMC4925273